Clinical Rheumatology

, Volume 27, Issue 5, pp 613–619 | Cite as

Analysis of the impact of fibromyalgia on quality of life: associated factors

  • Ma del Carmen Ubago Linares
  • Isabel Ruiz-Pérez
  • Ma José Bermejo Pérez
  • Antonio Olry de Labry-Lima
  • Elisa Hernández-Torres
  • Juncal Plazaola-Castaño
Original Article


We analysed the impact of fibromyalgia (FM) on the functional capacity of patients suffering this syndrome and identified factors that are associated with greater disease impact. We performed a cross-sectional descriptive telephone survey on all patients diagnosed with fibromyalgia during 2003 in a university hospital in Spain. Variables studied were socio-demographic, job, clinical, health and psycho-social characteristics of patients diagnosed with FM and impact of FM on them. Disease impact was measured by means of the Fibromyalgia Impact Questionnaire (FIQ). The rest of variables were collected by means of an expressly designed questionnaire. The relation between FIQ score and the other variables was performed with a bivariate analysis, using several tests depending on the variables involved. To analyse the factors associated with greatest disease impact, a multivariate linear regression model was designed. The average FIQ score for the sample was 63.6. Having a larger number of children, being tired and being in a depressed mood were the symptoms that most affected activities of daily living. A diagnosis of any mental illness, reference to repercussion on the family environment, a lower self-rated health and having consulted more specialists before FM diagnosis were associated with a higher impact after adjusting according to all the variables in the model. It can be confirmed that the FIQ is a useful instrument for measuring the impact of FM on quality of life. Identifying factors that determine the extent of its impact will enable more effective therapeutic strategies to be designed.


Fibromyalgia Quality of life 


  1. 1.
    Wolfe F, Smythe HA, Yunnus MB et al (1990) The American College of Rheumatology (1990) criteria for the classification of fibromyalgia. Arthritis Rheum 33:160–172PubMedCrossRefGoogle Scholar
  2. 2.
    WHO (1992) International statistical classification of diseases and related problems. ICD-10. WHO, GenevaGoogle Scholar
  3. 3.
    Wolfe F, Ross K, Anderson J et al (1995) The prevalence and characteristics of Fibromyalgia in the general population. Arthritis Rheum 38:19–28PubMedCrossRefGoogle Scholar
  4. 4.
    White KP, Speechley M, Harth M et al (1999) The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 26:1570–1576PubMedGoogle Scholar
  5. 5.
    Ballina FJ, Martín P, Iglesias A et al (1995) La fibromialgia. Revisión clínica. Rev Clin Esp 195:326–331Google Scholar
  6. 6.
    Mulero J (1997) Fibromialgia. Medicine 7:2682–2687Google Scholar
  7. 7.
    Valverde M, Juan A, Rivas B et al (2001) Fibromialgia. En: Estudio EPISER. Prevalencia e impacto de las enfermedades reumáticas en la población adulta española. Madrid: Msd y Sociedad Española de Reumatología 77–91Google Scholar
  8. 8.
    Ubago MC, Ruiz I, Bermejo MJ et al (2005) Características clínicas y psicosociales de personas con fibromialgia. Repercusión del diagnóstico sobre sus actividades. Rev Esp Salud Publica 79:683–695CrossRefGoogle Scholar
  9. 9.
    Arnold LM, Keck PE, Welge JA (2000) Antidepressant treatment of fibromyalgia. A metaanalysis and review. Psychosomatics 41:104–13PubMedCrossRefGoogle Scholar
  10. 10.
    Fernández MA (2000) Fibromialgia. Rev Esp Reumatol 27:442–446Google Scholar
  11. 11.
    Schochat T, Beckmann C (2003) Sociodemographic characteristics, risk factors and reproduced history in subjets whith fibromyalgia. Results of a population based case-control study. Z Rheumatol 62:46–59PubMedCrossRefGoogle Scholar
  12. 12.
    Patkar AA, Biloll, Masand PS (2003) Management of fibromyalgia. Curr Psychiatry Rep 5:218–224PubMedCrossRefGoogle Scholar
  13. 13.
    Wolfe F (1996) The fibromyalgia syndrome: a consensus report on fibromyalgia and disability. J Rheumatol 23:534–539PubMedGoogle Scholar
  14. 14.
    Wolfe F (1997) The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 56:268–271PubMedGoogle Scholar
  15. 15.
    Fitzcharles MA, Esdaile JM (1997) The overdiagnosis of fibromyalgia syndrome. Am J Med 103:44–50PubMedCrossRefGoogle Scholar
  16. 16.
    Edwards, Bingham C III, Bathon et al (2006) Catastrophizing and pain in arthritis, fibromyalgia, and other rheumatic diseases. Arthritis Care Research 55:325–332PubMedCrossRefGoogle Scholar
  17. 17.
    Okifuji A, Turk DC, Sherman JJ (2000) Evaluation of the relation-ship between depression and fibromyalgia syndrome: why aren’t all patients depressed? J Rheumatol 27:212–219PubMedGoogle Scholar
  18. 18.
    Beth JM (2002) Does chronic pain predict future psychological distress? Pain 96:239–245CrossRefGoogle Scholar
  19. 19.
    Suhr JA (2003) Neuropsychological impairment in fibromyalgia: relation to depression, fatigue and pain. J Psychosom Res 55:321–329PubMedCrossRefGoogle Scholar
  20. 20.
    Martínez E, González O, Crespo JM (2003) Fibromialgia: definición, aspectos clínicos, psicológicos, psiquiátricos y terapéuticos. Salud Mental 4:2–7Google Scholar
  21. 21.
    Forseth KO, Husby G, Gran JT et al (1999) Prognostic Factors for the development of fibromyalgia in women with self-reported musculoskeletal pain. A prospective study. J Rheumatol 26:2458–2467PubMedGoogle Scholar
  22. 22.
    Rivera J, Alegre C, Ballina FJ et al (2006) Documento de consenso de la Sociedad Española de Reumatología sobre la fibromialgia. Reumatol Clin 2(Supl 1):S55–S66Google Scholar
  23. 23.
    Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483PubMedCrossRefGoogle Scholar
  24. 24.
    Alonso J, Prieto L, Antó JM (1995) La versión española del SF-36 Health Survey (Cuestionario de salud SF-36): un instrumento para la medida de los resultados clínicos. Med Clin (Barc) 104:771–776Google Scholar
  25. 25.
    Burckardt CS, Clark SR, Bennet RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18:728–733Google Scholar
  26. 26.
    Bennet R (2005) The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 23(Suppl 39):154–162Google Scholar
  27. 27.
    Rivera J, González T (2004) The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol 22:554–560PubMedGoogle Scholar
  28. 28.
    Esteve-Vives J, Batlle-gualda E, Reig A (1993) Spanish version of the health assessment questionnaire: reliability, validity and transcultural equivalency. Grupo para la adaptación del HAQ a la población española. J Rheumatol 20:2216–2222Google Scholar
  29. 29.
    De Gracia M, Marco M, Ruiz J (2001) Evaluación de los aspectos psicológicos de la Fibromialgia. Anl Modif Conduct 21:959–980Google Scholar
  30. 30.
    Boonen A, van den Heuvel R, van Tubergen A et al (2005) Large differences in cost-of-illness and well being between patients with fibromyalgia, chronic low back pain or ankylosing spondylitis. Ann Rheum Dis 64:396–402PubMedCrossRefGoogle Scholar
  31. 31.
    Dönmez A, Zeki Karagülle M, Tercan N et al (2005) SPA therapy in fibromyalgia: a randomised controlled clinic study. Rheumatol Int 26:168–172PubMedCrossRefGoogle Scholar
  32. 32.
    Fallon J, Bujak DI, Guardino S et al (1999) The Fibromyalgia Impact Questionnaire: a useful tool in evaluating patients with post-Lyme disease syndrome. Arthritis Care Res 12:42–47PubMedCrossRefGoogle Scholar
  33. 33.
    White K, Speechley M, Harth M et al (1999) Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London (Ontario). Arthritis Rheum 42:76–83PubMedCrossRefGoogle Scholar
  34. 34.
    Gowans SE, Dehueck A, Voss S et al (2004) Six-month and one-year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Rheum 51:890–898PubMedCrossRefGoogle Scholar
  35. 35.
    Zijlstra TR, van de Laar MA, Bernelot HJ et al (2005) Spa treatment for primary fibromyalgia syndrome: a combination of thalassotherapy, exercise and patient education improves symptoms and quality of life. Rheumatology 44:539–546PubMedCrossRefGoogle Scholar
  36. 36.
    Yunus MB (1992) Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J Rheumatol 19:90–94PubMedGoogle Scholar
  37. 37.
    Bazzichi L, Giannaccini G, Betti L et al (2006) Alteration of serotonin transporter density and activity in fibromyalgia. Arthritis Res Ther 8:99CrossRefGoogle Scholar
  38. 38.
    Birtane M, Uzunca K, Tastekin N et al (2007) The evaluation of quality of life in fibromyalgia syndrome: a comparison with rheumatoid arthritis by using SF-36 Health Survey. Clin Rheumatol 26:679–684PubMedCrossRefGoogle Scholar
  39. 39.
    Salomon L, Reeves W (2004) Factors influencing the diagnosis of chronic fatigue syndrome. Arch Intern Med 164:2241–2245CrossRefGoogle Scholar
  40. 40.
    Martin DP, Sletten CD, Williams BA et al (2006) Improvement in fibromyalgia symptoms with acupuncture: results of a randomized controlled trial. Mayo Clin Proc 81:749–757PubMedCrossRefGoogle Scholar
  41. 41.
    Assis MR, Silva LE, Alves M et al (2006) A randomized controlled trial of deep water running: clinical effectiveness of aquatic exercise to treat fibromyalgia. Arthritis Rheum 55:57–65PubMedCrossRefGoogle Scholar
  42. 42.
    Culos-Reed S, Brawley L (2000) Fibromyalgia, physical activity, and daily functioning: the importance of efficacy and health-related quality of life. Arthritis Care Res 13:343–351PubMedCrossRefGoogle Scholar
  43. 43.
    Croft P (1994) Population study of tender points counts and pain as evidence of fibromyalgia. BMJ 309:696–699PubMedGoogle Scholar
  44. 44.
    O’Malley P (2000) Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Inter Medicine 15:659–666CrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2007

Authors and Affiliations

  • Ma del Carmen Ubago Linares
    • 1
  • Isabel Ruiz-Pérez
    • 1
  • Ma José Bermejo Pérez
    • 1
  • Antonio Olry de Labry-Lima
    • 1
  • Elisa Hernández-Torres
    • 1
  • Juncal Plazaola-Castaño
    • 1
  1. 1.Escuela Andaluza de Salud PúblicaGranadaSpain

Personalised recommendations